Tremor clinical trials

Explore recruiting tremor clinical trials.

Recruiting tremor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tremor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult patients with essential tremor

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Severe Residual Tremor in Participants with Parkinson’s Disease

Spain, Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Kan skattning av njurfunktion (eGFR) förutsäga vilka patienter med S. aureus-bakteremi som behöver justerad dosering via monitorering av kloxacillinkoncentrationer i plasma (TDM)?

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Tremor trials by city

Tremor in Toronto Tremor in Vancouver Tremor in Montreal Tremor in Calgary Tremor in Edmonton Tremor in Ottawa Tremor in Winnipeg Tremor in Quebec City Tremor in Hamilton Tremor in Kitchener Tremor in London Tremor in Halifax Tremor in New York Tremor in Los Angeles Tremor in Chicago Tremor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease